Hardin et al [8] demonstrated that dehydroepiandrosterone sulphate (DHEAS) exposure, even in the presence of tamoxifen and fulvestrant, induced changes in ER and PgR gene expression that may be partially responsible for breast cancer progression. The gene discussed is PGR; the disease is breast carcinoma.